

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein-chromophore linkage (GO:0018298) | 9.99581381 |
| 2 | retinal rod cell development (GO:0046548) | 9.38938739 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 9.28136077 |
| 4 | visual perception (GO:0007601) | 8.85949463 |
| 5 | sensory perception of light stimulus (GO:0050953) | 8.75672381 |
| 6 | lymphangiogenesis (GO:0001946) | 8.09671203 |
| 7 | cellular response to light stimulus (GO:0071482) | 7.47007731 |
| 8 | cellular response to zinc ion (GO:0071294) | 7.35685922 |
| 9 | eye photoreceptor cell differentiation (GO:0001754) | 7.23836937 |
| 10 | photoreceptor cell differentiation (GO:0046530) | 7.23836937 |
| 11 | detection of external stimulus (GO:0009581) | 7.12353315 |
| 12 | detection of abiotic stimulus (GO:0009582) | 6.97790039 |
| 13 | retina development in camera-type eye (GO:0060041) | 6.67992776 |
| 14 | cellular response to cadmium ion (GO:0071276) | 6.65008989 |
| 15 | regulation of cGMP metabolic process (GO:0030823) | 6.47653888 |
| 16 | endothelium development (GO:0003158) | 6.38809613 |
| 17 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.97399271 |
| 18 | signal peptide processing (GO:0006465) | 5.82653378 |
| 19 | regulation of cGMP biosynthetic process (GO:0030826) | 5.61091851 |
| 20 | tachykinin receptor signaling pathway (GO:0007217) | 5.60096592 |
| 21 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 5.38630020 |
| 22 | positive regulation of cGMP metabolic process (GO:0030825) | 5.27798170 |
| 23 | response to gravity (GO:0009629) | 5.16834058 |
| 24 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.16464924 |
| 25 | nonmotile primary cilium assembly (GO:0035058) | 4.89713141 |
| 26 | cellular response to radiation (GO:0071478) | 4.81735262 |
| 27 | adaptation of signaling pathway (GO:0023058) | 4.73678437 |
| 28 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.60346218 |
| 29 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.50085591 |
| 30 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 4.49198525 |
| 31 | negative regulation of norepinephrine secretion (GO:0010700) | 4.35261074 |
| 32 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.34244608 |
| 33 | nodal signaling pathway (GO:0038092) | 4.32393663 |
| 34 | semaphorin-plexin signaling pathway (GO:0071526) | 4.26395719 |
| 35 | sensory perception (GO:0007600) | 4.14688533 |
| 36 | endothelial tube morphogenesis (GO:0061154) | 4.12217050 |
| 37 | morphogenesis of an endothelium (GO:0003159) | 4.12217050 |
| 38 | positive regulation of gastrulation (GO:2000543) | 4.12208713 |
| 39 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.10983547 |
| 40 | lymph vessel development (GO:0001945) | 4.08186924 |
| 41 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.07337287 |
| 42 | regulation of bile acid biosynthetic process (GO:0070857) | 4.00101227 |
| 43 | sprouting angiogenesis (GO:0002040) | 3.99396474 |
| 44 | estrogen biosynthetic process (GO:0006703) | 3.92949823 |
| 45 | response to light stimulus (GO:0009416) | 3.91380425 |
| 46 | arginine catabolic process (GO:0006527) | 3.88374878 |
| 47 | neurofilament cytoskeleton organization (GO:0060052) | 3.83223102 |
| 48 | prenylation (GO:0097354) | 3.81689014 |
| 49 | protein prenylation (GO:0018342) | 3.81689014 |
| 50 | retina layer formation (GO:0010842) | 3.80926524 |
| 51 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.76110278 |
| 52 | neuron development (GO:0048666) | 3.71706229 |
| 53 | ganglion development (GO:0061548) | 3.62914282 |
| 54 | phospholipid scrambling (GO:0017121) | 3.59560554 |
| 55 | regulation of stem cell maintenance (GO:2000036) | 3.57479360 |
| 56 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.52449619 |
| 57 | venous blood vessel morphogenesis (GO:0048845) | 3.45854141 |
| 58 | negative regulation of activin receptor signaling pathway (GO:0032926) | 3.42969325 |
| 59 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.42093789 |
| 60 | protein localization to synapse (GO:0035418) | 3.38902793 |
| 61 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.38340845 |
| 62 | forebrain neuron differentiation (GO:0021879) | 3.37025825 |
| 63 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.34147855 |
| 64 | endothelial cell differentiation (GO:0045446) | 3.31790552 |
| 65 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.31712624 |
| 66 | negative regulation of catecholamine secretion (GO:0033604) | 3.30830742 |
| 67 | cellular response to vitamin D (GO:0071305) | 3.30750691 |
| 68 | short-term memory (GO:0007614) | 3.29052435 |
| 69 | erythrocyte maturation (GO:0043249) | 3.27355837 |
| 70 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.27321748 |
| 71 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.25077889 |
| 72 | retina homeostasis (GO:0001895) | 3.22264798 |
| 73 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.18417454 |
| 74 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.15941872 |
| 75 | heart trabecula morphogenesis (GO:0061384) | 3.13831519 |
| 76 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.13740414 |
| 77 | hepatocyte differentiation (GO:0070365) | 3.12311205 |
| 78 | behavioral response to ethanol (GO:0048149) | 3.12204355 |
| 79 | chemosensory behavior (GO:0007635) | 3.12058375 |
| 80 | protein-cofactor linkage (GO:0018065) | 3.11081252 |
| 81 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.10877994 |
| 82 | labyrinthine layer development (GO:0060711) | 3.10720985 |
| 83 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.10236965 |
| 84 | blood vessel maturation (GO:0001955) | 3.09462581 |
| 85 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.09379543 |
| 86 | cerebellar granule cell differentiation (GO:0021707) | 3.08179259 |
| 87 | retinoid metabolic process (GO:0001523) | 3.07875023 |
| 88 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.05537450 |
| 89 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.05537450 |
| 90 | primitive streak formation (GO:0090009) | 3.05408488 |
| 91 | activin receptor signaling pathway (GO:0032924) | 3.04429853 |
| 92 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.04074846 |
| 93 | hemoglobin metabolic process (GO:0020027) | 3.03195056 |
| 94 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.03113242 |
| 95 | regulation of penile erection (GO:0060405) | 3.02590001 |
| 96 | negative regulation of microtubule polymerization (GO:0031115) | 3.02394969 |
| 97 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.99921518 |
| 98 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.98098061 |
| 99 | patterning of blood vessels (GO:0001569) | 2.97697140 |
| 100 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.95472843 |
| 101 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.95123952 |
| 102 | positive regulation of protein kinase C signaling (GO:0090037) | 2.94216684 |
| 103 | response to histamine (GO:0034776) | 2.91780792 |
| 104 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90041769 |
| 105 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.89138680 |
| 106 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.88804700 |
| 107 | lens morphogenesis in camera-type eye (GO:0002089) | 2.88077110 |
| 108 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.87811395 |
| 109 | cell migration involved in gastrulation (GO:0042074) | 2.87308300 |
| 110 | regulation of sarcomere organization (GO:0060297) | 2.86213772 |
| 111 | synaptic transmission, dopaminergic (GO:0001963) | 2.86194760 |
| 112 | membrane hyperpolarization (GO:0060081) | 2.85974111 |
| 113 | single strand break repair (GO:0000012) | 2.85597338 |
| 114 | diterpenoid metabolic process (GO:0016101) | 2.85036269 |
| 115 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.84484770 |
| 116 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.82789368 |
| 117 | synaptic vesicle maturation (GO:0016188) | 2.79755803 |
| 118 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.79204620 |
| 119 | regulation of gonadotropin secretion (GO:0032276) | 2.78484596 |
| 120 | embryonic heart tube development (GO:0035050) | 2.77256584 |
| 121 | positive regulation of vasculogenesis (GO:2001214) | 2.76935954 |
| 122 | modulation by virus of host process (GO:0019054) | 2.75088741 |
| 123 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.73866757 |
| 124 | phospholipid translocation (GO:0045332) | 2.71468884 |
| 125 | lipid translocation (GO:0034204) | 2.71468884 |
| 126 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.70080045 |
| 127 | axoneme assembly (GO:0035082) | 2.69609474 |
| 128 | female pregnancy (GO:0007565) | 2.69494250 |
| 129 | trabecula morphogenesis (GO:0061383) | 2.68981989 |
| 130 | response to zinc ion (GO:0010043) | 2.68695507 |
| 131 | embryonic process involved in female pregnancy (GO:0060136) | 2.68629360 |
| 132 | digestive tract morphogenesis (GO:0048546) | 2.67557746 |
| 133 | response to radiation (GO:0009314) | 2.67438426 |
| 134 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.67246644 |
| 135 | female genitalia development (GO:0030540) | 2.66140311 |
| 136 | vasculature development (GO:0001944) | 2.64061427 |
| 137 | ectodermal placode formation (GO:0060788) | 2.62508204 |
| 138 | terpenoid metabolic process (GO:0006721) | 2.62054375 |
| 139 | regulation of norepinephrine secretion (GO:0014061) | 2.61283580 |
| 140 | lung vasculature development (GO:0060426) | 2.60520370 |
| 141 | arachidonic acid secretion (GO:0050482) | 2.58688715 |
| 142 | icosanoid secretion (GO:0032309) | 2.58688715 |
| 143 | arginine metabolic process (GO:0006525) | 2.58469670 |
| 144 | basement membrane organization (GO:0071711) | 2.58089751 |
| 145 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.58039979 |
| 146 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.56894816 |
| 147 | mitochondrion transport along microtubule (GO:0047497) | 2.56894816 |
| 148 | regulation of vasculogenesis (GO:2001212) | 2.56531310 |
| 149 | auditory behavior (GO:0031223) | 2.51594492 |
| 150 | positive regulation of cyclase activity (GO:0031281) | 2.51307327 |
| 151 | neural tube development (GO:0021915) | 2.51044194 |
| 152 | dopamine receptor signaling pathway (GO:0007212) | 2.48856087 |
| 153 | norepinephrine metabolic process (GO:0042415) | 2.46519106 |
| 154 | platelet dense granule organization (GO:0060155) | 2.43938638 |
| 155 | cellular response to abiotic stimulus (GO:0071214) | 2.43661220 |
| 156 | lipoprotein transport (GO:0042953) | 2.43014096 |
| 157 | glucocorticoid biosynthetic process (GO:0006704) | 2.40903920 |
| 158 | paraxial mesoderm development (GO:0048339) | 2.39715666 |
| 159 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.39517155 |
| 160 | negative regulation of cation channel activity (GO:2001258) | 2.39441317 |
| 161 | cellular potassium ion homeostasis (GO:0030007) | 2.39317233 |
| 162 | post-embryonic morphogenesis (GO:0009886) | 2.39149943 |
| 163 | adrenal gland development (GO:0030325) | 2.38892774 |
| 164 | retinol metabolic process (GO:0042572) | 2.38601027 |
| 165 | fatty acid elongation (GO:0030497) | 2.37673762 |
| 166 | axon extension (GO:0048675) | 2.37115837 |
| 167 | endoderm formation (GO:0001706) | 2.36580314 |
| 168 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.35755312 |
| 169 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.35755312 |
| 170 | positive regulation of macroautophagy (GO:0016239) | 2.33546632 |
| 171 | regulation of RNA export from nucleus (GO:0046831) | 2.33316278 |
| 172 | protein carboxylation (GO:0018214) | 2.32915477 |
| 173 | behavioral response to cocaine (GO:0048148) | 2.32156708 |
| 174 | positive regulation of lyase activity (GO:0051349) | 2.29278906 |
| 175 | establishment of mitochondrion localization (GO:0051654) | 2.26909818 |
| 176 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 18.3120067 |
| 177 | rhodopsin mediated signaling pathway (GO:0016056) | 17.7971011 |
| 178 | retinal cone cell development (GO:0046549) | 16.0840698 |
| 179 | photoreceptor cell development (GO:0042461) | 12.7321936 |
| 180 | eye photoreceptor cell development (GO:0042462) | 12.2568110 |
| 181 | photoreceptor cell maintenance (GO:0045494) | 11.8200416 |
| 182 | detection of light stimulus involved in sensory perception (GO:0050962) | 10.9742639 |
| 183 | detection of light stimulus involved in visual perception (GO:0050908) | 10.9742639 |
| 184 | phototransduction (GO:0007602) | 10.7942560 |
| 185 | phototransduction, visible light (GO:0007603) | 10.7099910 |
| 186 | detection of visible light (GO:0009584) | 10.2704649 |
| 187 | positive regulation of guanylate cyclase activity (GO:0031284) | 10.2656311 |
| 188 | detection of light stimulus (GO:0009583) | 10.1953957 |
| 189 | GMP metabolic process (GO:0046037) | 10.1732455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.02154117 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.75692910 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.02813100 |
| 4 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 4.72392311 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.28633831 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.04714928 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.99747157 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.84079933 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.80875391 |
| 10 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.77847644 |
| 11 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.75177080 |
| 12 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.75177080 |
| 13 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.75177080 |
| 14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.51700625 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.41248646 |
| 16 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.33738970 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.18725509 |
| 18 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.06642234 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.04939369 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.02218259 |
| 21 | GATA1_19941826_ChIP-Seq_K562_Human | 1.91176229 |
| 22 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90521116 |
| 23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87791316 |
| 24 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.87207067 |
| 25 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.87127785 |
| 26 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.81937755 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.80004849 |
| 28 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.78484368 |
| 29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.76624143 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.70538319 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70332747 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66660496 |
| 33 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.66092472 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65931609 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.62646182 |
| 36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.61049154 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.60715631 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59586717 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59288684 |
| 40 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58973852 |
| 41 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.58859968 |
| 42 | AR_19668381_ChIP-Seq_PC3_Human | 1.56438078 |
| 43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.55124573 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.53263510 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51353183 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.50392357 |
| 47 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.50156079 |
| 48 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.46607218 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46229247 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.44718467 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.43367650 |
| 52 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.42448844 |
| 53 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.41959507 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41880900 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.41406825 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.39819180 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.39618430 |
| 58 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38544493 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37625721 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37061991 |
| 61 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.35577453 |
| 62 | TBL1_22424771_ChIP-Seq_293T_Human | 1.35177051 |
| 63 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33969525 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33219641 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31281170 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29494127 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29494127 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28825055 |
| 69 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.27813060 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27811585 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27370217 |
| 72 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26406132 |
| 73 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.24202898 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23980991 |
| 75 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.23969134 |
| 76 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22327656 |
| 77 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.22237810 |
| 78 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.21166995 |
| 79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.20561020 |
| 80 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.20046646 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19670281 |
| 82 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.19072453 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16593487 |
| 84 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16420427 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16408486 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16193763 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14311346 |
| 88 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.13532389 |
| 89 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.13513214 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12721367 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12465009 |
| 92 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10827468 |
| 93 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.10517864 |
| 94 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09028695 |
| 95 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.08705976 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 1.08487957 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08173949 |
| 98 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.07676877 |
| 99 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.07530960 |
| 100 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.07315427 |
| 101 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06341188 |
| 102 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06038831 |
| 103 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.05850027 |
| 104 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.04731283 |
| 105 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04319305 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03881442 |
| 107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03823019 |
| 108 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01756211 |
| 109 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01688586 |
| 110 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.01439375 |
| 111 | NCOR_22424771_ChIP-Seq_293T_Human | 1.01237645 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00873058 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00433949 |
| 114 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.00095974 |
| 115 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99701038 |
| 116 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99000195 |
| 117 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.98940752 |
| 118 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98892214 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98871906 |
| 120 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98222417 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97378021 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97156021 |
| 123 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97133069 |
| 124 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96414300 |
| 125 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95165628 |
| 126 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94736259 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94607388 |
| 128 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94314714 |
| 129 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93163816 |
| 130 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92856436 |
| 131 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.92681148 |
| 132 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91820103 |
| 133 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.91816683 |
| 134 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.91197656 |
| 135 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90902902 |
| 136 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90725478 |
| 137 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90420236 |
| 138 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89788154 |
| 139 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.89733143 |
| 140 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89511419 |
| 141 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.89444650 |
| 142 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.89286171 |
| 143 | SA1_27219007_Chip-Seq_Bcells_Human | 0.89266416 |
| 144 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88395975 |
| 145 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87692326 |
| 146 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.86622168 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85872086 |
| 148 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85749646 |
| 149 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85435798 |
| 150 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.84971881 |
| 151 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84547045 |
| 152 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84348311 |
| 153 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84229845 |
| 154 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.84184022 |
| 155 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.84157756 |
| 156 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83726811 |
| 157 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83718348 |
| 158 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83284557 |
| 159 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82780176 |
| 160 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.82626515 |
| 161 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.82208386 |
| 162 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81700837 |
| 163 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.79709831 |
| 164 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.77835930 |
| 165 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.77768256 |
| 166 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.76082193 |
| 167 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75586916 |
| 168 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.72451443 |
| 169 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72321179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 8.22562429 |
| 2 | MP0005253_abnormal_eye_physiology | 6.89906829 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.76839413 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 5.09823014 |
| 5 | MP0003950_abnormal_plasma_membrane | 4.18953608 |
| 6 | MP0005195_abnormal_posterior_eye | 3.98705275 |
| 7 | MP0001324_abnormal_eye_pigmentation | 3.55973091 |
| 8 | MP0005083_abnormal_biliary_tract | 3.40402871 |
| 9 | MP0005391_vision/eye_phenotype | 3.38454547 |
| 10 | MP0002090_abnormal_vision | 2.99921471 |
| 11 | MP0002638_abnormal_pupillary_reflex | 2.89861238 |
| 12 | MP0004147_increased_porphyrin_level | 2.76372879 |
| 13 | MP0003123_paternal_imprinting | 2.69181204 |
| 14 | MP0002229_neurodegeneration | 2.67442561 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.35492742 |
| 16 | MP0001764_abnormal_homeostasis | 2.23613941 |
| 17 | MP0002822_catalepsy | 2.09360393 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 2.02056826 |
| 19 | MP0003878_abnormal_ear_physiology | 2.02056826 |
| 20 | MP0003011_delayed_dark_adaptation | 10.6120627 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 10.0158232 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.98117447 |
| 23 | MP0002752_abnormal_somatic_nervous | 1.97480595 |
| 24 | MP0005167_abnormal_blood-brain_barrier | 1.92774706 |
| 25 | MP0003567_abnormal_fetal_cardiomyocyte | 1.89402936 |
| 26 | MP0002254_reproductive_system_inflammat | 1.86253916 |
| 27 | MP0001299_abnormal_eye_distance/ | 1.83682761 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.81147159 |
| 29 | MP0004133_heterotaxia | 1.79708329 |
| 30 | MP0001346_abnormal_lacrimal_gland | 1.73451680 |
| 31 | MP0003119_abnormal_digestive_system | 1.70683563 |
| 32 | MP0001986_abnormal_taste_sensitivity | 1.55136904 |
| 33 | MP0004272_abnormal_basement_membrane | 1.49848778 |
| 34 | MP0008260_abnormal_autophagy | 1.46312338 |
| 35 | MP0002882_abnormal_neuron_morphology | 1.43240365 |
| 36 | MP0009053_abnormal_anal_canal | 1.40902534 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.39682507 |
| 38 | MP0008995_early_reproductive_senescence | 1.36907125 |
| 39 | MP0005409_darkened_coat_color | 1.35841585 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.29264647 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.26708606 |
| 42 | MP0000537_abnormal_urethra_morphology | 1.25362778 |
| 43 | MP0004233_abnormal_muscle_weight | 1.23270166 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.23251439 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.20813118 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.16374739 |
| 47 | MP0003828_pulmonary_edema | 1.15110013 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.14022880 |
| 49 | MP0004885_abnormal_endolymph | 1.10740572 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.01087741 |
| 51 | MP0000566_synostosis | 0.96610715 |
| 52 | MP0001188_hyperpigmentation | 0.96557146 |
| 53 | MP0005197_abnormal_uvea_morphology | 0.95312859 |
| 54 | MP0000955_abnormal_spinal_cord | 0.93125357 |
| 55 | MP0004270_analgesia | 0.93022154 |
| 56 | MP0005410_abnormal_fertilization | 0.92553159 |
| 57 | MP0001984_abnormal_olfaction | 0.89799494 |
| 58 | MP0003935_abnormal_craniofacial_develop | 0.89225789 |
| 59 | MP0002925_abnormal_cardiovascular_devel | 0.87982992 |
| 60 | MP0005623_abnormal_meninges_morphology | 0.87775797 |
| 61 | MP0003984_embryonic_growth_retardation | 0.87712572 |
| 62 | MP0005187_abnormal_penis_morphology | 0.86841688 |
| 63 | MP0002088_abnormal_embryonic_growth/wei | 0.85456033 |
| 64 | MP0003186_abnormal_redox_activity | 0.84754892 |
| 65 | MP0002092_abnormal_eye_morphology | 0.84083523 |
| 66 | MP0003634_abnormal_glial_cell | 0.83190134 |
| 67 | MP0001486_abnormal_startle_reflex | 0.80989622 |
| 68 | MP0003942_abnormal_urinary_system | 0.80219516 |
| 69 | MP0003938_abnormal_ear_development | 0.79760410 |
| 70 | MP0008775_abnormal_heart_ventricle | 0.79602342 |
| 71 | MP0001672_abnormal_embryogenesis/_devel | 0.79416283 |
| 72 | MP0005380_embryogenesis_phenotype | 0.79416283 |
| 73 | MP0006292_abnormal_olfactory_placode | 0.76625068 |
| 74 | MP0000647_abnormal_sebaceous_gland | 0.76068890 |
| 75 | MP0003948_abnormal_gas_homeostasis | 0.74721718 |
| 76 | MP0001440_abnormal_grooming_behavior | 0.74643180 |
| 77 | MP0005394_taste/olfaction_phenotype | 0.74410445 |
| 78 | MP0005499_abnormal_olfactory_system | 0.74410445 |
| 79 | MP0003861_abnormal_nervous_system | 0.73683242 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.72314862 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.72183589 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.71633511 |
| 83 | MP0004510_myositis | 0.71250429 |
| 84 | MP0003385_abnormal_body_wall | 0.71172786 |
| 85 | MP0009697_abnormal_copulation | 0.69731914 |
| 86 | MP0003941_abnormal_skin_development | 0.69426135 |
| 87 | MP0002127_abnormal_cardiovascular_syste | 0.69162234 |
| 88 | MP0002084_abnormal_developmental_patter | 0.66476532 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.64806146 |
| 90 | MP0003121_genomic_imprinting | 0.64667270 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 0.64244237 |
| 92 | MP0002272_abnormal_nervous_system | 0.63493471 |
| 93 | MP0000767_abnormal_smooth_muscle | 0.61568940 |
| 94 | MP0003787_abnormal_imprinting | 0.59945954 |
| 95 | MP0002295_abnormal_pulmonary_circulatio | 0.59944576 |
| 96 | MP0001286_abnormal_eye_development | 0.59505949 |
| 97 | MP0008789_abnormal_olfactory_epithelium | 0.59394449 |
| 98 | MP0003880_abnormal_central_pattern | 0.59292045 |
| 99 | MP0008770_decreased_survivor_rate | 0.58809963 |
| 100 | MP0004859_abnormal_synaptic_plasticity | 0.57129854 |
| 101 | MP0002734_abnormal_mechanical_nocicepti | 0.52122308 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.51568262 |
| 103 | MP0002064_seizures | 0.51176698 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 0.50690600 |
| 105 | MP0003635_abnormal_synaptic_transmissio | 0.49310468 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.49194663 |
| 107 | MP0009046_muscle_twitch | 0.44240614 |
| 108 | MP0008004_abnormal_stomach_pH | 0.44077978 |
| 109 | MP0002067_abnormal_sensory_capabilities | 0.40314540 |
| 110 | MP0002063_abnormal_learning/memory/cond | 0.39075971 |
| 111 | MP0004924_abnormal_behavior | 0.38105467 |
| 112 | MP0005386_behavior/neurological_phenoty | 0.38105467 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.37686883 |
| 114 | MP0002572_abnormal_emotion/affect_behav | 0.37092943 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.34138592 |
| 116 | MP0001968_abnormal_touch/_nociception | 0.31952032 |
| 117 | MP0009745_abnormal_behavioral_response | 0.30582253 |
| 118 | MP0003045_fibrosis | 0.30452142 |
| 119 | MP0001915_intracranial_hemorrhage | 0.30343972 |
| 120 | MP0009780_abnormal_chondrocyte_physiolo | 0.29929759 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.29020612 |
| 122 | MP0004085_abnormal_heartbeat | 0.28816962 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.28749397 |
| 124 | MP0002697_abnormal_eye_size | 0.28398826 |
| 125 | MP0003890_abnormal_embryonic-extraembry | 0.27969568 |
| 126 | MP0004742_abnormal_vestibular_system | 0.27565958 |
| 127 | MP0000631_abnormal_neuroendocrine_gland | 0.27264920 |
| 128 | MP0000026_abnormal_inner_ear | 0.25936996 |
| 129 | MP0003252_abnormal_bile_duct | 0.25156524 |
| 130 | MP0008569_lethality_at_weaning | 0.25147757 |
| 131 | MP0005620_abnormal_muscle_contractility | 0.25033919 |
| 132 | MP0004043_abnormal_pH_regulation | 0.24055607 |
| 133 | MP0002152_abnormal_brain_morphology | 0.22810169 |
| 134 | MP0002066_abnormal_motor_capabilities/c | 0.22622906 |
| 135 | MP0005248_abnormal_Harderian_gland | 0.22281046 |
| 136 | MP0003632_abnormal_nervous_system | 0.22040321 |
| 137 | MP0002928_abnormal_bile_duct | 0.21632517 |
| 138 | MP0005193_abnormal_anterior_eye | 0.20744463 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.19789698 |
| 140 | MP0002184_abnormal_innervation | 0.18768149 |
| 141 | MP0008961_abnormal_basal_metabolism | 0.17975153 |
| 142 | MP0004811_abnormal_neuron_physiology | 0.17877352 |
| 143 | MP0003943_abnormal_hepatobiliary_system | 0.17846504 |
| 144 | MP0005330_cardiomyopathy | 0.16325397 |
| 145 | MP0000778_abnormal_nervous_system | 0.15998517 |
| 146 | MP0000749_muscle_degeneration | 0.15144611 |
| 147 | MP0004142_abnormal_muscle_tone | 0.15117468 |
| 148 | MP0003646_muscle_fatigue | 0.14897821 |
| 149 | MP0002102_abnormal_ear_morphology | 0.14543030 |
| 150 | MP0010030_abnormal_orbit_morphology | 0.14233351 |
| 151 | MP0003638_abnormal_response/metabolism_ | 0.14183709 |
| 152 | MP0000751_myopathy | 0.13554504 |
| 153 | MP0003633_abnormal_nervous_system | 0.13112299 |
| 154 | MP0001661_extended_life_span | 0.11899251 |
| 155 | MP0001905_abnormal_dopamine_level | 0.11500768 |
| 156 | MP0002108_abnormal_muscle_morphology | 0.11334625 |
| 157 | MP0003631_nervous_system_phenotype | 0.11274630 |
| 158 | MP0001614_abnormal_blood_vessel | 0.10809655 |
| 159 | MP0002909_abnormal_adrenal_gland | 0.10582426 |
| 160 | MP0001293_anophthalmia | 0.10558358 |
| 161 | MP0002971_abnormal_brown_adipose | 0.10087881 |
| 162 | MP0005595_abnormal_vascular_smooth | 0.09884945 |
| 163 | MP0000001_mammalian_phenotype | 0.08680306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dyschromatopsia (HP:0007641) | 9.78669264 |
| 2 | Pigmentary retinal degeneration (HP:0001146) | 9.33934812 |
| 3 | Chorioretinal atrophy (HP:0000533) | 9.02325035 |
| 4 | Central scotoma (HP:0000603) | 8.36039186 |
| 5 | Pendular nystagmus (HP:0012043) | 8.17844956 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 7.91231078 |
| 7 | Scotoma (HP:0000575) | 7.41908510 |
| 8 | Attenuation of retinal blood vessels (HP:0007843) | 7.40197901 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 7.15177894 |
| 10 | Decreased central vision (HP:0007663) | 6.44230317 |
| 11 | Intestinal atresia (HP:0011100) | 6.35719745 |
| 12 | Photophobia (HP:0000613) | 5.73589082 |
| 13 | Vitreoretinal degeneration (HP:0000655) | 5.63780529 |
| 14 | Type II diabetes mellitus (HP:0005978) | 5.63031958 |
| 15 | Oligodactyly (hands) (HP:0001180) | 5.54128231 |
| 16 | Macular degeneration (HP:0000608) | 5.23927586 |
| 17 | Severe visual impairment (HP:0001141) | 5.11784253 |
| 18 | Posterior subcapsular cataract (HP:0007787) | 5.02714155 |
| 19 | Increased corneal curvature (HP:0100692) | 5.02052064 |
| 20 | Keratoconus (HP:0000563) | 5.02052064 |
| 21 | Deep palmar crease (HP:0006191) | 4.91786752 |
| 22 | Cone-rod dystrophy (HP:0000548) | 4.89954422 |
| 23 | Esophageal atresia (HP:0002032) | 4.71089420 |
| 24 | Chin dimple (HP:0010751) | 4.55128887 |
| 25 | Constricted visual fields (HP:0001133) | 4.49475358 |
| 26 | Choroideremia (HP:0001139) | 4.43362654 |
| 27 | Retinitis pigmentosa (HP:0000510) | 4.39008689 |
| 28 | Congenital malformation of the right heart (HP:0011723) | 4.28043765 |
| 29 | Double outlet right ventricle (HP:0001719) | 4.28043765 |
| 30 | Aqueductal stenosis (HP:0002410) | 4.19431246 |
| 31 | Nuclear cataract (HP:0100018) | 3.98689744 |
| 32 | Oligodactyly (HP:0012165) | 3.85680494 |
| 33 | Anosmia (HP:0000458) | 3.71225116 |
| 34 | Down-sloping shoulders (HP:0200021) | 3.70100422 |
| 35 | Septo-optic dysplasia (HP:0100842) | 3.67339467 |
| 36 | Abnormal pancreas size (HP:0012094) | 3.67056673 |
| 37 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.67004891 |
| 38 | Labial hypoplasia (HP:0000066) | 3.64396411 |
| 39 | Mixed hearing impairment (HP:0000410) | 3.58860286 |
| 40 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.47098558 |
| 41 | Hypoplastic female external genitalia (HP:0012815) | 3.38996843 |
| 42 | Progressive visual loss (HP:0000529) | 3.09760086 |
| 43 | Subcapsular cataract (HP:0000523) | 3.05949843 |
| 44 | Retinal atrophy (HP:0001105) | 2.96253843 |
| 45 | Hemivertebrae (HP:0002937) | 2.91632999 |
| 46 | Tetraparesis (HP:0002273) | 2.91316196 |
| 47 | Growth hormone deficiency (HP:0000824) | 2.85694946 |
| 48 | Absent eyebrow (HP:0002223) | 2.85501767 |
| 49 | Anophthalmia (HP:0000528) | 2.82526192 |
| 50 | Gastrointestinal atresia (HP:0002589) | 2.79309796 |
| 51 | Anal stenosis (HP:0002025) | 2.75543428 |
| 52 | Optic disc pallor (HP:0000543) | 2.68973878 |
| 53 | Horseshoe kidney (HP:0000085) | 2.66162270 |
| 54 | Reticulocytosis (HP:0001923) | 2.64741257 |
| 55 | Overfolded helix (HP:0000396) | 2.60878035 |
| 56 | Hypogonadotrophic hypogonadism (HP:0000044) | 2.58859560 |
| 57 | Cerebral aneurysm (HP:0004944) | 2.57992933 |
| 58 | Partial duplication of thumb phalanx (HP:0009944) | 2.57802880 |
| 59 | Nonimmune hydrops fetalis (HP:0001790) | 2.54094808 |
| 60 | Wide nasal bridge (HP:0000431) | 2.51019241 |
| 61 | Abnormally folded helix (HP:0008544) | 2.50093107 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.43528348 |
| 63 | Abnormality of the labia (HP:0000058) | 2.43121653 |
| 64 | Turricephaly (HP:0000262) | 2.38889624 |
| 65 | Gait imbalance (HP:0002141) | 2.35762131 |
| 66 | Congenital primary aphakia (HP:0007707) | 2.33927717 |
| 67 | Abnormality of the musculature of the hand (HP:0001421) | 2.33150052 |
| 68 | Abdominal situs inversus (HP:0003363) | 2.28748148 |
| 69 | Abnormality of abdominal situs (HP:0011620) | 2.28748148 |
| 70 | Absent septum pellucidum (HP:0001331) | 2.27060504 |
| 71 | Absent eyelashes (HP:0000561) | 2.24543979 |
| 72 | Myokymia (HP:0002411) | 2.22861274 |
| 73 | Anterior segment dysgenesis (HP:0007700) | 2.21735240 |
| 74 | Partial duplication of the phalanx of hand (HP:0009999) | 2.20872675 |
| 75 | Limb dystonia (HP:0002451) | 2.15866407 |
| 76 | Diastasis recti (HP:0001540) | 2.15280020 |
| 77 | Stenosis of the external auditory canal (HP:0000402) | 2.14229691 |
| 78 | Absent radius (HP:0003974) | 2.13195053 |
| 79 | Long palpebral fissure (HP:0000637) | 2.12215636 |
| 80 | Nephrogenic diabetes insipidus (HP:0009806) | 2.06755001 |
| 81 | Abnormality of reticulocytes (HP:0004312) | 2.05572212 |
| 82 | Absent forearm bone (HP:0003953) | 2.02131379 |
| 83 | Aplasia involving forearm bones (HP:0009822) | 2.02131379 |
| 84 | Pulmonic stenosis (HP:0001642) | 2.01074097 |
| 85 | Hepatoblastoma (HP:0002884) | 2.00529589 |
| 86 | Congenital stationary night blindness (HP:0007642) | 13.5296853 |
| 87 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.4378667 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.7609956 |
| 89 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.3043191 |
| 90 | Cholecystitis (HP:0001082) | 1.99392805 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 1.99392805 |
| 92 | Choanal stenosis (HP:0000452) | 1.97390052 |
| 93 | Medial flaring of the eyebrow (HP:0010747) | 1.97205134 |
| 94 | Ileus (HP:0002595) | 1.94769617 |
| 95 | Vesicoureteral reflux (HP:0000076) | 1.91137221 |
| 96 | Polycythemia (HP:0001901) | 1.90566421 |
| 97 | Maternal diabetes (HP:0009800) | 1.89149282 |
| 98 | Renal hypoplasia (HP:0000089) | 1.85932125 |
| 99 | Thickened helices (HP:0000391) | 1.85301147 |
| 100 | Renal duplication (HP:0000075) | 1.84110521 |
| 101 | Arterial tortuosity (HP:0005116) | 1.83516296 |
| 102 | Disproportionate tall stature (HP:0001519) | 1.82060235 |
| 103 | Abnormality of the septum pellucidum (HP:0007375) | 1.80011049 |
| 104 | Progressive inability to walk (HP:0002505) | 1.79526948 |
| 105 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.79432534 |
| 106 | Poor coordination (HP:0002370) | 1.79070464 |
| 107 | Spondylolisthesis (HP:0003302) | 1.77090556 |
| 108 | Poikilocytosis (HP:0004447) | 1.76672466 |
| 109 | Metaphyseal dysplasia (HP:0100255) | 1.76110267 |
| 110 | Bilateral microphthalmos (HP:0007633) | 1.74544882 |
| 111 | Lymphangioma (HP:0100764) | 1.74371721 |
| 112 | Cupped ear (HP:0000378) | 1.74170059 |
| 113 | Paralysis (HP:0003470) | 1.73665389 |
| 114 | Abnormality of the antihelix (HP:0009738) | 1.71762886 |
| 115 | Generalized hypotonia (HP:0001290) | 1.70503537 |
| 116 | Horizontal nystagmus (HP:0000666) | 1.70102360 |
| 117 | Polar cataract (HP:0010696) | 1.69557152 |
| 118 | Cholelithiasis (HP:0001081) | 1.69167707 |
| 119 | Hydronephrosis (HP:0000126) | 1.67496372 |
| 120 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.65590467 |
| 121 | Abnormality of the parietal bone (HP:0002696) | 1.65265157 |
| 122 | Hypoplasia of the ulna (HP:0003022) | 1.64856445 |
| 123 | Bifid scrotum (HP:0000048) | 1.64255181 |
| 124 | Abnormality of the duodenum (HP:0002246) | 1.64012565 |
| 125 | Optic atrophy (HP:0000648) | 1.61867133 |
| 126 | Capillary hemangiomas (HP:0005306) | 1.61826704 |
| 127 | Vaginal atresia (HP:0000148) | 1.60880684 |
| 128 | Split hand (HP:0001171) | 1.60839851 |
| 129 | Hypoalphalipoproteinemia (HP:0003233) | 1.56732180 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 1.56507507 |
| 131 | Severe Myopia (HP:0011003) | 1.54089157 |
| 132 | Genital tract atresia (HP:0001827) | 1.53742740 |
| 133 | True hermaphroditism (HP:0010459) | 1.36849230 |
| 134 | Dysdiadochokinesis (HP:0002075) | 1.36094615 |
| 135 | Pancreatic fibrosis (HP:0100732) | 1.35818069 |
| 136 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.31899576 |
| 137 | Retinal detachment (HP:0000541) | 1.14865417 |
| 138 | Cystic liver disease (HP:0006706) | 1.12277096 |
| 139 | Epileptic encephalopathy (HP:0200134) | 1.11762394 |
| 140 | Pancreatic cysts (HP:0001737) | 1.10271227 |
| 141 | Astigmatism (HP:0000483) | 1.08583402 |
| 142 | Abnormality of the fovea (HP:0000493) | 1.00769060 |
| 143 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.97495252 |
| 144 | Left ventricular hypertrophy (HP:0001712) | 0.95848094 |
| 145 | Specific learning disability (HP:0001328) | 0.95703690 |
| 146 | Broad foot (HP:0001769) | 0.95384982 |
| 147 | Truncal ataxia (HP:0002078) | 0.95112509 |
| 148 | Febrile seizures (HP:0002373) | 0.93972758 |
| 149 | Sclerocornea (HP:0000647) | 0.93568685 |
| 150 | Hypoplasia of the fovea (HP:0007750) | 0.93368473 |
| 151 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 0.93368473 |
| 152 | Progressive cerebellar ataxia (HP:0002073) | 0.92513374 |
| 153 | Cerebellar dysplasia (HP:0007033) | 0.91889050 |
| 154 | Chorioretinal coloboma (HP:0000567) | 0.90717153 |
| 155 | Asthma (HP:0002099) | 0.87887797 |
| 156 | Hypermetropia (HP:0000540) | 0.87433340 |
| 157 | Decreased testicular size (HP:0008734) | 0.87141983 |
| 158 | Genetic anticipation (HP:0003743) | 0.86456049 |
| 159 | Recurrent sinusitis (HP:0011108) | 0.85370535 |
| 160 | Visual hallucinations (HP:0002367) | 0.81410773 |
| 161 | Furrowed tongue (HP:0000221) | 0.81097498 |
| 162 | Molar tooth sign on MRI (HP:0002419) | 0.75397063 |
| 163 | Abnormality of midbrain morphology (HP:0002418) | 0.75397063 |
| 164 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.72812448 |
| 165 | Anencephaly (HP:0002323) | 0.71748483 |
| 166 | Prolonged QT interval (HP:0001657) | 0.70664109 |
| 167 | Partial agenesis of the corpus callosum (HP:0001338) | 0.69329915 |
| 168 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.66938434 |
| 169 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.66863548 |
| 170 | Dental crowding (HP:0000678) | 0.65689987 |
| 171 | Hypodontia (HP:0000668) | 0.65400816 |
| 172 | Postaxial hand polydactyly (HP:0001162) | 0.65372419 |
| 173 | Lymphopenia (HP:0001888) | 0.64071945 |
| 174 | Congenital hepatic fibrosis (HP:0002612) | 0.63498680 |
| 175 | Short foot (HP:0001773) | 0.63482218 |
| 176 | Macroorchidism (HP:0000053) | 0.63225721 |
| 177 | Dysmetric saccades (HP:0000641) | 0.62815415 |
| 178 | Chronic hepatic failure (HP:0100626) | 0.61210458 |
| 179 | Generalized myoclonic seizures (HP:0002123) | 0.60880287 |
| 180 | Abnormality of the fingertips (HP:0001211) | 0.58149914 |
| 181 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.57922778 |
| 182 | Abnormality of dental color (HP:0011073) | 0.56736501 |
| 183 | Gaze-evoked nystagmus (HP:0000640) | 0.56733614 |
| 184 | Broad-based gait (HP:0002136) | 0.56396430 |
| 185 | Abnormal EKG (HP:0003115) | 0.55048653 |
| 186 | Urinary bladder sphincter dysfunction (HP:0002839) | 0.55044941 |
| 187 | Abnormality of the parathyroid morphology (HP:0011766) | 0.55004210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 7.33756890 |
| 2 | TIE1 | 5.38018722 |
| 3 | KDR | 3.70040907 |
| 4 | PINK1 | 3.27473080 |
| 5 | DYRK3 | 3.13603892 |
| 6 | LATS2 | 3.04345448 |
| 7 | ERBB4 | 3.02545503 |
| 8 | IRAK3 | 2.83963915 |
| 9 | IRAK2 | 2.64798203 |
| 10 | TGFBR2 | 2.62302660 |
| 11 | EPHB2 | 2.24020364 |
| 12 | BRAF | 2.12943731 |
| 13 | SIK3 | 2.03707868 |
| 14 | GRK1 | 10.9267209 |
| 15 | DAPK2 | 1.90261236 |
| 16 | MAP3K10 | 1.85118624 |
| 17 | SIK2 | 1.77818844 |
| 18 | ADRBK1 | 1.70291157 |
| 19 | STK24 | 1.64069123 |
| 20 | MARK2 | 1.63695259 |
| 21 | CAMK1G | 1.61343018 |
| 22 | MAP3K9 | 1.59859928 |
| 23 | PRPF4B | 1.58244867 |
| 24 | MAPK12 | 1.53887562 |
| 25 | STK39 | 1.53050753 |
| 26 | BRD4 | 1.48580460 |
| 27 | CDK12 | 1.43936081 |
| 28 | MAPK7 | 1.43284766 |
| 29 | BMPR1B | 1.39004513 |
| 30 | STK38L | 1.33739125 |
| 31 | MAPK13 | 1.31720020 |
| 32 | CAMK1D | 1.30964296 |
| 33 | HIPK2 | 1.29074212 |
| 34 | SGK223 | 1.26185542 |
| 35 | SGK494 | 1.26185542 |
| 36 | MET | 1.25823192 |
| 37 | PAK6 | 1.23960222 |
| 38 | BMX | 1.23059835 |
| 39 | PRKD3 | 1.21981594 |
| 40 | BCR | 1.21648867 |
| 41 | STK3 | 1.19316933 |
| 42 | PNCK | 1.15585924 |
| 43 | TAOK3 | 1.14862946 |
| 44 | ARAF | 1.13934747 |
| 45 | MAP3K4 | 1.11808172 |
| 46 | FGFR2 | 1.10888004 |
| 47 | STK38 | 1.10706735 |
| 48 | NME1 | 1.10230991 |
| 49 | PTK6 | 1.06593031 |
| 50 | MARK1 | 1.06257565 |
| 51 | PRKCH | 1.05885067 |
| 52 | CSNK1D | 1.04724026 |
| 53 | SGK2 | 1.04718550 |
| 54 | ERBB2 | 1.02770424 |
| 55 | PTK2B | 1.02718148 |
| 56 | EIF2AK1 | 1.02426753 |
| 57 | RPS6KA4 | 1.02138706 |
| 58 | ILK | 1.01471452 |
| 59 | AKT3 | 1.00773923 |
| 60 | BUB1 | 0.99712938 |
| 61 | NTRK1 | 0.98345209 |
| 62 | SGK3 | 0.96118058 |
| 63 | ICK | 0.89748851 |
| 64 | TAOK1 | 0.89585372 |
| 65 | CAMKK1 | 0.88461845 |
| 66 | TYRO3 | 0.87034829 |
| 67 | DYRK2 | 0.87032285 |
| 68 | INSRR | 0.83440355 |
| 69 | PRKCZ | 0.83233813 |
| 70 | WNK1 | 0.81216158 |
| 71 | ACVR1B | 0.80987263 |
| 72 | NEK1 | 0.77326007 |
| 73 | OXSR1 | 0.77072254 |
| 74 | PRKG2 | 0.75803076 |
| 75 | PDGFRA | 0.75644791 |
| 76 | NME2 | 0.72650010 |
| 77 | PRKAA1 | 0.70509263 |
| 78 | PRKCB | 0.70477569 |
| 79 | CAMK2D | 0.68830344 |
| 80 | FLT3 | 0.68461534 |
| 81 | TAOK2 | 0.66830856 |
| 82 | MYLK | 0.65963724 |
| 83 | LRRK2 | 0.64949949 |
| 84 | DAPK1 | 0.64936825 |
| 85 | DYRK1A | 0.64925076 |
| 86 | FES | 0.64799755 |
| 87 | PTK2 | 0.63825733 |
| 88 | LATS1 | 0.63572957 |
| 89 | PRKACG | 0.61151421 |
| 90 | STK16 | 0.61146620 |
| 91 | PRKAA2 | 0.60408898 |
| 92 | CDK19 | 0.60296483 |
| 93 | GRK5 | 0.59511406 |
| 94 | RPS6KA3 | 0.59446039 |
| 95 | DYRK1B | 0.58874361 |
| 96 | TLK1 | 0.58727229 |
| 97 | PLK2 | 0.58301551 |
| 98 | BRSK2 | 0.55444823 |
| 99 | SIK1 | 0.54621185 |
| 100 | PAK1 | 0.54553181 |
| 101 | PHKG2 | 0.54473796 |
| 102 | PHKG1 | 0.54473796 |
| 103 | ABL2 | 0.53607593 |
| 104 | RAF1 | 0.53023477 |
| 105 | PRKD2 | 0.51184024 |
| 106 | MINK1 | 0.51177768 |
| 107 | MAP3K8 | 0.50885468 |
| 108 | CAMK1 | 0.50321019 |
| 109 | CDK5 | 0.50117047 |
| 110 | TTK | 0.49575863 |
| 111 | DAPK3 | 0.49506078 |
| 112 | FGFR1 | 0.48680251 |
| 113 | TAF1 | 0.47189449 |
| 114 | GSK3B | 0.47013197 |
| 115 | PIK3CA | 0.46343288 |
| 116 | SGK1 | 0.45009363 |
| 117 | MARK3 | 0.44010754 |
| 118 | NEK6 | 0.43954666 |
| 119 | PRKDC | 0.43766464 |
| 120 | AKT1 | 0.43719648 |
| 121 | MAPK9 | 0.43330647 |
| 122 | CDK9 | 0.43311051 |
| 123 | CAMK4 | 0.43135367 |
| 124 | NEK2 | 0.43019277 |
| 125 | MAPK14 | 0.42773853 |
| 126 | MAP2K7 | 0.41819518 |
| 127 | MAPK10 | 0.41438546 |
| 128 | WEE1 | 0.41104132 |
| 129 | MAP3K7 | 0.40672751 |
| 130 | PDK2 | 0.40525751 |
| 131 | CASK | 0.40473601 |
| 132 | MAP3K11 | 0.39826958 |
| 133 | MAP2K4 | 0.39340531 |
| 134 | SCYL2 | 0.38994604 |
| 135 | CDK3 | 0.36917501 |
| 136 | PAK4 | 0.36196336 |
| 137 | BRSK1 | 0.35995780 |
| 138 | CDK1 | 0.35757512 |
| 139 | PLK3 | 0.35400133 |
| 140 | CDK11A | 0.35229962 |
| 141 | AKT2 | 0.35061994 |
| 142 | ALK | 0.34178332 |
| 143 | STK11 | 0.33592827 |
| 144 | CAMK2A | 0.32561365 |
| 145 | PKN1 | 0.30748204 |
| 146 | PRKACA | 0.30663477 |
| 147 | PRKCG | 0.29663453 |
| 148 | MAP3K3 | 0.29561021 |
| 149 | TGFBR1 | 0.28612146 |
| 150 | KSR1 | 0.28128996 |
| 151 | UHMK1 | 0.27308070 |
| 152 | RPS6KA2 | 0.27259307 |
| 153 | PAK3 | 0.27227774 |
| 154 | CSNK1E | 0.26732428 |
| 155 | WNK4 | 0.26673942 |
| 156 | PDGFRB | 0.26438241 |
| 157 | MAPK8 | 0.25754130 |
| 158 | RPS6KB1 | 0.25290703 |
| 159 | MAPK3 | 0.23882523 |
| 160 | PRKCA | 0.23115984 |
| 161 | PRKD1 | 0.22904270 |
| 162 | NTRK3 | 0.21592932 |
| 163 | TNK2 | 0.20571871 |
| 164 | CDC42BPA | 0.20275513 |
| 165 | CHEK1 | 0.20097032 |
| 166 | ATM | 0.19771919 |
| 167 | PRKACB | 0.19712989 |
| 168 | MKNK2 | 0.17727383 |
| 169 | CDK2 | 0.17591651 |
| 170 | NTRK2 | 0.17484236 |
| 171 | MTOR | 0.17251140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.07907806 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.02033788 |
| 3 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.01644399 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 16.0077127 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 1.90941792 |
| 6 | Axon guidance_Homo sapiens_hsa04360 | 1.90453744 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 1.87109651 |
| 8 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.81827095 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62931518 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 1.57958842 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.50554334 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 1.48128541 |
| 13 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.41580687 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.40884899 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40531451 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.40372597 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29904669 |
| 18 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.19231907 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16327991 |
| 20 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.14028839 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08467383 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07133982 |
| 23 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00040087 |
| 24 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.98936912 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98593837 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97944958 |
| 27 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.97186404 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97037762 |
| 29 | Cell cycle_Homo sapiens_hsa04110 | 0.95238670 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93096247 |
| 31 | Pathways in cancer_Homo sapiens_hsa05200 | 0.91668781 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91668545 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.90255867 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89175108 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86363505 |
| 36 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86361026 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.85787629 |
| 38 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.85017744 |
| 39 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83020900 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82157049 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 0.81598175 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81496903 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81414868 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79930915 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78835250 |
| 46 | Bladder cancer_Homo sapiens_hsa05219 | 0.78787280 |
| 47 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.78511278 |
| 48 | Morphine addiction_Homo sapiens_hsa05032 | 0.78095975 |
| 49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77892956 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77890891 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76880300 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 0.76648020 |
| 53 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.76147350 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74898637 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73940421 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72348627 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 0.70864063 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70500760 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65781004 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65662383 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65641456 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65585240 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.62090769 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61398927 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 0.58997172 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55621397 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55619581 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.54926798 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.54619758 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54285307 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54282379 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.52517493 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52494409 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.51954026 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51531110 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51289162 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50157739 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49025380 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48337325 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48202394 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47902525 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47294203 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47279297 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46101172 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.42933815 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40711707 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38423141 |
| 88 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38419180 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37755501 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.36934015 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36489231 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34702270 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34500683 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33353198 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.30347206 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30278452 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.30172529 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30145661 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30068376 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30025026 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29646567 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.29563554 |
| 103 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.28712810 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.26653408 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26337183 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25228307 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24900986 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24509705 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24242426 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23825144 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.23792870 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23669592 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22292614 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21994971 |
| 115 | Alcoholism_Homo sapiens_hsa05034 | 0.19878298 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19763682 |
| 117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.17940293 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.17615787 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17166738 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.17097143 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16054496 |
| 122 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15672852 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14857562 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.14670331 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14470369 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.13213190 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12619767 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.12363544 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.12265471 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.11181898 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10969023 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10641626 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.10441922 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.09622896 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.09485571 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.09262803 |
| 137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.09177058 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.09044126 |
| 139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08980876 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.08401549 |
| 141 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.07816283 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07228321 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.07183269 |
| 144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06166401 |
| 145 | Glioma_Homo sapiens_hsa05214 | 0.06065999 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05940174 |
| 147 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.04415576 |
| 148 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.03930211 |
| 149 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.03879822 |
| 150 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.03564378 |
| 151 | Endocytosis_Homo sapiens_hsa04144 | 0.03557493 |
| 152 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.03476962 |
| 153 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.03143621 |
| 154 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.03101406 |
| 155 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.03059149 |
| 156 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.02864374 |
| 157 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.02801157 |
| 158 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.02398986 |
| 159 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.02129127 |
| 160 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01669579 |

